# Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

> **NCT04341454** · PHASE3 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 327 (actual)

## Conditions studied

- Acute Gastritis
- Chronic Gastritis

## Interventions

- **DRUG:** DWP14012 X mg
- **DRUG:** DWP14012 X mg placebo
- **DRUG:** DWP14012 Y mg
- **DRUG:** DWP14012 Y mg placebo

## Key facts

- **NCT ID:** NCT04341454
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-02
- **Primary completion:** 2021-08-04
- **Final completion:** 2021-09-16
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341454, "Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04341454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*